Member Info for peterobert

Ondine Biomedical Inc - Vancouver-based life sciences company - Raises GBP2.5 million via placing and subscription. Further, in light of the demand for the placing and subscription, increases overall fundraising size from GBP2.5 million cap as commitments already received mean that there are insufficient shares to allocate to the broker option or to employee subscribers.

Expect 15p very soon

imho - dyor

RBC says overperform with target 60p

Currently 9.35-9.95p

It is all up from here

imho - dyor

We are pleased to have the support of existing and new investors through this fundraising which meets our near-term working capital needs and assists our rapid commercial growth rate. This funding will take us forward commercially and further our discussions with industry partners on our clinical, financial, and global distribution objectives.

We believe that our product, Steriwave, is very well positioned to help hospitals meet their infection control objectives, reduce their antibiotic usage and combat AMR in what will be a multibillion-dollar market. Our commercial efforts are benefitting both from the growing support for pre-surgical nasal decolonisation by leading organisations, as well as our real-world clinical successes in Canadian hospitals over the last 10 years.

While we are currently focused on nasal decolonisation to prevent healthcare-associated infections, we have a pipeline of products in various stages of development using the same platform technology. These platform products target the treatment of burns, wounds, chronic sinusitis, ventilator-associated pneumonia, and fungal infections and will leverage our regulatory filings and the clinical successes related to our nasal decolonisation product."

The only way is up

imho - dyor

8.36-8.68

Great time to buy cause it wont stay down for long

imho - dyor

The results of the study showed that treatment with photodisinfection resulted in >99.9% reduction of viable bacteria compared to the control, regardless of the antibiotic susceptibility of the bacteria. The authors concluded that photodisinfection is likely an important adjunct to AMR strategies in the future and that further clinical studies are warranted.

Antimicrobial resistance (AMR) remains a major public health concern, causing 33,000 deaths in Europe annually( 1 (#_edn1) ) which is projected to rise to over 10 million globally by 2050.( 2 (#_edn2) ) There are widespread multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections across the world which are mainly caused by Gram-negative bacteria including Enterobacteriaceae and P. aeruginosa AMR bacteria( 3 (#_edn3) )(,( 4 (#_edn4) )) and Gram-positive bacteria such as Staphylococcus spp.( 5 (#_edn5) ) Steriwave has been found to be highly effective against all these pathogens.

Photodisinfection uses a photosensitizer and a specific wavelength of light to trigger photochemical reactions that produce reactive oxygen species. These reactive oxygen species are lethal to a broad spectrum of microbes, including bacteria, fungi, and viruses. Importantly, photodisinfection does not induce antimicrobial resistance formation.

Says it all

"With our this simple, 5-minute, painless intervention our Steriwave treatment makes a life-saving impact - in this case, 468 spine surgery patients saved from potentially lethal infections - more than enough to fill a 747 plane. We are truly grateful to Professor Street and the research staff at VGH for their pursuit of better patient outcomes. Postoperative spine infection can be a devastating and expensive complication after spine surgery, with patients at high risk for chronic pain, paralysis, return to the operating room, poor long-term outcomes, and even death. This study conclusively demonstrates that Steriwave is setting a new standard for safety and performance in infection control."

**END**

9.6-9.975

very small margin

Expecting a JUMP

when next good news

arrives

dyor - imho

Hasbeen

Has been short listed

This is good news

International recognition

is very important

Read the half year report

It looks good in my opinion

Bodes well for getting to breakeven

in 2024 with all great news of more

hospitals coming on line and brand

recognition gaining momentum

surpassing all expectations

imho - dyor

Just bought more @ 9.67p

Am expecting a JUMP

imho - dyor

All indications are that this is a multi-bagger investment opportunity currently below 10p

RBC target is 60p and personally I have no doubt SP will exceed that

imho - dyor

Photodisinfection uses a photosensitizer and a specific wavelength of light to trigger photochemical reactions that produce reactive oxygen species. These reactive oxygen species are lethal to a broad spectrum of microbes, including bacteria, fungi, and viruses. Importantly, photodisinfection does not induce antimicrobial resistance formation.

Photodisinfection is an easy-to-use alternative to topical antibiotics and antifungals because it is highly effective against all types of disease-causing pathogens, including MDR and XDR strains.

Ondine has pioneered nasal photodisinfection as a rapid, non-antibiotic method for decolonizing the nose of the pathogens carried by patients that can lead to HAIs. Steriwave uses a proprietary red light-activated agent to eliminate infection-causing bacteria, viruses, and fungi in the nose, a major reservoir of germs[2], without causing resistance. At the Mazankowski Alberta Heart Institute, Steriwave replaced the previous standard of care, the antibiotic mupirocin. Mupirocin is commonly used for nasal decolonization to prevent SSIs, but has poor rates of patient compliance and reported resistance rates as high as 81%.[3]

10.025-10.34p

good time to buy in my opinion

(before more great news makes SP rise)

dyor

10.575-11.195p

my purchase earlier is shown as sell

It is a good time to buy more (before sky-rocket)

imho - dyor

Nova Scotia's largest hospital is the latest to implement Steriwave nasal photodisinfection for use prior to orthopedic surgery Canadian life sciences company Ondine Biomedical's (LON: OBI) Steriwave® nasal photodisinfection for the prevention of healthcare-associated infections (HAIs) is now available in hospitals across Canada. The latest hospital to implement Steriwave for its orthopedic surgery patients is the Queen Elizabeth II Health Sciences Centre in Halifax, affiliated with Dalhousie University and the largest hospital in Nova Scotia, located on Canada's East Coast.

Steriwave is a highly effective method of preventing infections following surgery. This is particularly important due to growing concern about antimicrobial resistance (AMR), as hospitals must adapt their protocols to combat the rapid rise of drug-resistant pathogens